10/14/2022Helsinn Pulls the Plug on Its $2.4B Liver Cancer Deal with BridgeBio

10/14/2022Recent Executive Moves

10/14/2022Drug R&D and Product Registration News Digest October 2022 (1)

10/13/2022IASO and Cabaletta Announce Global License Deal for Clinically Validat...

10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)

10/11/2022AI Poised to Take Chinese Drug Discovery to the Next Level

10/11/2022Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGen...

10/11/2022HanAll's Licensed Partner in China Enters Sublicense Deal with CSPC to...

10/10/2022BGI Genomics Added to U.S. Investment Ban List

10/10/2022CDE Solicits Comments on Draft Technical Guidelines for Microbial Limi...

10/10/2022NMPA Begins Issuance of Electronic Drug Registration Certificate

10/10/2022Genentech and Jemincare Enter $650M Biobucks Pact for Latter's Prosta...

10/10/2022Bayer, Hua Medicine Snag First-In-Class Nod in China for Roche Castoff...

10/9/2022CDE Issues the Technical Guidelines for Bioequivalence Studies of Aspi...

10/9/2022CDE Solicits Comments on Draft Opinions for Reform and Improvement of ...

10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Proto...

10/9/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (63...

10/8/2022U.S. Adds 31 Additional Chinese Cos to Unverified List, But Removing A...

10/6/2022AIM Vaccine Launches IPO on the Main Board of SEHK

10/6/2022Telemedicine Expanded to Rural China: Across the Divide

10/6/2022Senate Blesses Bill to Wrest US Supply Chains from China's Grasp, with...

10/4/2022Chinese Pharma Firms' US Expansion Plans to Come Up Against Brick Wall...

10/4/2022China's 2022 NRDL Outlook (PharmExec)

10/4/2022Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...

10/4/2022China Pharma Slapped with Listing Deficiency Notification from NYSE Am...

10/3/2022YishengBio to List on Nasdaq Via A $230M SPAC Transaction

10/2/2022NH Reports MAT H1/2022 Data on the Chinese Cough, Cold and Allergy Mar...

9/30/2022CDE Issues the List of Reference Formulations for GQCE Studies (60th B...

9/30/2022NMPA Announces Package Insert Revision of Cefazolin Injection

Page:69/719 Total number of articles:21546: [First][<<] [67] [68] [69] [70] [71] [>>] [End]